Pelvic inflammatory disease (PID) is an acute infection usually originating in the uterine cervix, which may cause endometritis, salpingitis, oophoritis, pelvic abscess, peritonitis and/or perihepatitis.
Early diagnosis and treatment prevent late sequelae of PID:
infertility due to fallopian tube damage
ectopic pregnancy
chronic abdominal pain.
Epidemiology
PID mainly occurs in sexually active women of reproductive age. The risk of PID is highest in the youngest age groups.
If the clinical picture in a postmenopausal patient resembles PID, careful differential diagnosis is required (high risk of malignancy).
Usually a mixed infection, and the causative pathogens cannot necessarily be detected by microbiological methods.
Chlamydia trachomatisChlamydia and Neisseria gonorrhoeae Gonorrhoea often cause PID in women of reproductive age. An estimated 10-15% of cervical chlamydial or gonococcal infections proceed to PID.
Mycoplasma genitalium is another probable cause of PID in premenopausal patients.
Anaerobic bacteria in the vaginal microbiome may also be associated with PID.
Intestinal or respiratory tract bacteria are involved more rarely.
Inserting an IUD will increase the risk of PID for a few weeks.
Clinical picture
The possibility of PID must be kept in mind if a patient of reproductive age presents with lower abdominal pain and abnormal vaginal discharge. The clinical diagnosis can be made based on typical symptoms and findings and basic investigations.
The clinical picture varies from nearly asymptomatic to life-threatening.
To avoid consequences affecting fertility, PID should be diagnosed and treatment started without hesitation in patients of reproductive age.
Treatment should be chosen to cover the most important potential causative bacteria and also a mixed infection; treatment should be directed at chlamydia, gonorrhoea and anaerobic bacteria.
Outpatient management if:
the patient's general condition is good
inflammatory markers are only slightly increased.
Antimicrobial treatment in outpatient care
Doxycycline 100 mg twice daily for 14 days and metronidazole 400 mg three times daily for 14 days
If gonorrhoea is diagnosed
a single dose of ceftriaxone 1 g i.m. should be added to the regimen, and
a gonococcal culture sample should preferably be taken for antimicrobial susceptibility testing before starting the treatment (see Gonorrhoea).
If gonorrhoea or chlamydia is diagnosed, ensure contact tracing (see Chlamydia).
If chlamydial and gonococcal infections can be excluded and the infection occurs after the insertion of an IUD, for example, it is usually a mixed infection caused by normal vaginal flora.
This can be treated with a combination of cephalexin (500 mg three times daily or 750 mg twice daily) and metronidazole (500 mg twice daily or 400 mg three times daily).
Indications for hospital treatment
Severe symptoms: high fever, poor general condition
Complicated PID: suspected abscess in the lesser pelvis
After the patient's clinical condition improves, intravenous antimicrobial treatment should be continued for another day. It can then be replaced by oral medication.
Doxycycline 100 mg twice daily and metronidazole 400 mg three times daily to make the total duration of treatment 14 days
Symptomatic treatment: NSAID, rest, sick leave
If a patient with PID has an IUD, it should be removed if PID is refractory to antimicrobial treatment.
Remember to arrange postcoital contraception and further contraception, as necessary.
If PID was due to chlamydia or gonorrhoea, a control sample (nucleic acid detection test for chlamydia and gonorrhoea) should be taken 4 weeks after the end of treatment.
The sexual partner(s) should be examined: samples for chlamydia and gonorrhoea tests.
Prognosis
PID should be readily treated to prevent any late complications.
PID may damage the fallopian tubes, leading to subfertility.
A single case of PID with treatment begun at an early stage will hardly affect fertility.
The risk of infertility is increased if the patient has had severe PID or several episodes of PID.
PID may increase the risk of ectopic pregnancy to some extent.
About 30% of patients develop chronic pelvic pain.
References
Ross J, Guaschino S, Cusini M, et al. 2017 European guideline for the management of pelvic inflammatory disease. Int J STD AIDS 2018;29(2):108-114 [PubMed]